Clinical Trial Update: A Study of S-892216-PO in Participants With Renal Impairment and Matched Controls [Phase 1]

View source ↗

Summary

A Phase 1 trial update for S-892216-PO in participants with renal impairment and matched controls, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Impairment

Drugs mentioned

• S-892216-PO (S-892216-PO)

Snippet

Sponsor: Shionogi | Conditions: Renal Impairment | Phase 1 | Status: RECRUITING